China Medical Technologies Announces Change of Independent Auditors
... manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please ...NeoGenomics Schedules Its Q2 2009 Earnings Release for July 28, 2009
... testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs ...NeoGenomics to Present at Noble Financial's 5th Annual Equity Conference on Monday, June 8th
... testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs ...New Tests Spot Tough-to-Detect Cancers Sooner
... is then performed to look for abnormally shaped cells, a search repeated with the additional use of digital image analysis and fluorescence in situ hybridization (FISH). The latter procedure uses colored probes visible with a fluorescence microscope to seek abnormal cells. In the study, nearly 500 people ...Study to Investigate AHCC and the Swine Flu Virus
... research specifically against the swine flu." What is AHCC (Active Hexose Correlated Compound)? AHCC is a natural compound derived from the hybridization of several subspecies of medicinal mushroom. AHCC is used by hundreds of healthcare facilities around the world and by hospitals as a part of a ...Mayo Clinic finds new pathology tests double sensitivity to detect bile duct and pancreatic cancers
... procedure, and cell brushings were taken. Brushings were then analyzed by routine cytology, digital image analysis and fluorescence in situ hybridization (FISH) to determine the various tests' effectiveness and sensitivity in detecting and diagnosing cancer. While traditional cytology analysis relies ...AdvanDx Receives FDA 510(k) Clearance for EK/P. aeruginosa PNA FISH(R)
... therapy and save patient lives. About PNA FISH(R) PNA FISH is an easy-to-use and highly sensitive and specific fluorescence in situ hybridization (FISH) assay that uses PNA (peptide nucleic acid) probes to target species specific ribosomal RNA (rRNA) in live bacteria and yeast. The unique ...Natural Killer Cells May Help Protect Against New Strains of Influenza Virus
... and Immunology, and Nutrition and Food. About Active Hexose Correlated Compound (AHCC): AHCC is a unique natural compound derived from the hybridization of several subspecies of medicinal mushrooms. AHCC is utilized by several hundred hospitals and healthcare facilities throughout Asia as a ...Quest Diagnostics Discovers New Genetic Mutations Affecting Cystic Fibrosis Screening
... company announced that it operates one of only three laboratories approved by the state of New York to perform microarray-based comparative genomic hybridization (aCGH) postnatal testing, using its ClariSure aCGH postnatal test, for copy-number chromosomal abnormalities implicated in mental retardation, birth ...NeoGenomics, Inc. Reports First Quarter 2009 Financial Results
... testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs ...NeoGenomics Schedules its Q1 2009 Earnings Release for April 23, 2009
... testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs ...PGD Technology Offers More Than Designer Babies
... genetic markers located near the mutation of interest can be used to identify affected embryos. Using a technique known as Fluorescent In Situ hybridization (FISH), PGD can also be used to count the chromosomes in the cell removed from an embryo. A normal cell has a complement of 23 pairs of chromosomes ...NeoGenomics Appoints Douglas M. VanOort as Executive Chairman and Interim Chief Executive Officer
... testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs ...NeoGenomics to Present at the Roth Capital Partner's 21st Annual OC Growth Stock Conference
... testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs ...NRL partners with industry to develop compact biosensor for wide-ranging applications
... particles to biomolecules, such as proteins or single-stranded DNA, scientists could then perform standard sandwich-type immuno or nucleic acid hybridization assays over the GMR sensors. The GMR sensors, each covered with complementary protein or single-stranded DNA (the "probe"), could then detect the ...China Medical Technologies Announces the Completion of the Sale of its HIFU Business
... manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please ...NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008
... diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs ...China Medical Technologies to Attend Credit Suisse Asian Healthcare Conference
... develops, manufactures and markets advanced in-vitro diagnostic products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ hybridization (FISH) technology, to detect and monitor various diseases and disorders, and system using High Intensity Focused Ultrasound (HIFU) for the treatment ...NeoGenomics to Present at the Noble Financial Equity Conference
... diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs ...Veridex Completes Acquisition of Immunicon Corporation Assets
... prostate cancer. As part of the agreement, Veridex also received all technologies related to Repeat-Free(TM) (RF) Poseidon(TM) Fluorescent In-Situ hybridization (FISH) Probes, which are the latest advance in FISH DNA probes. "This asset purchase ensures the role of CellSearch(TM) in the future of Veridex," ...NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
... diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs ...China Medical Technologies Reports Fourth Quarter and Full Year Financial Results
... develops, manufactures and markets advanced in-vitro diagnostic products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ hybridization (FISH) technology, to detect and monitor various diseases and disorders, and system using High Intensity Focused Ultrasound (HIFU) for the treatment ...Bioniche Presents Pre-Clinical Research at Two International Conferences
... out in conjunction with the Cytogenetic Laboratory, Miller School of Medicine, University of Miami, Miami, Florida, U.S.A. Using fluorescence in situ hybridization (FISH), the chromosomal status of bladder cancer cell lines commonly used in bladder cancer research was determined. The results of the study showed ...Scientists at Yale provide explanation for how cancer spreads
... and these molecules were the same as those used by metastatic cells in human cancers. Pawelek and his team then validated previous findings that hybridization occurs naturally in mice, and results in metastatic cancer. Viewing the fusion of a cancer cell and a white blood cell as the initiating event ...